Barau C, Braun J, Vincent C,
Haim-Boukobza S, Molina JM, Miailhes P, Fournier I, Aboulker JP,
Vittecoq D, Duclos-Vallée JC, Taburet AM, Teicher 6; Agence Nationale de
Recherche sur le Sida et les hépatites (ANRS) 148 Study Group. Pharmacokinetic
Study of Raltegravir in HIV-Infected Patients With End-Stage Liver
Disease: The LIVERAL-ANRS 148 Study. Clin Infect Dis. 2014 Oct
15;59(8):1177-84. doi: 10.1093/cid/ciu515. Epub 2014 Jul 3. Lien PubMed
Cotte L, Braun J, Lascoux-Combe
C, Vincent C, Valantin MA, Sogni P, Lacombe K, Neau D, Aumaitre H,
Batisse D, de Truchis P, Gervais A, Michelet C, Morlat P, Vittecoq D,
Rosa I, Bertucci I, Chevaliez S, Aboulker JP, Molina JM; for the French
National Agency for Research on AIDS and Viral Hepatitis (ANRS) HC26
Study Group. Telaprevir for HIV/Hepatitis C Virus–Coinfected
Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS
HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial. Clin Infect
Dis. 2014 Aug 18. Lien PubMed
Desaint C, Durier C, Poda A,
Krivine A, Simon F, Bodilis H, Pialoux G, Cuzin L, Poizot-Martin I,
Morineau P I, Lelievre JD, Silbermann B, Aoulker JP, Launay O for the
ANRS COHVAC Cohort and the Vaccine Research Institute (VRI). Long-term persistence of vaccine-induced HIV seropositivity in healthy volunteers. JAIDS Clin Res 2014, 5:2 Lien
Diane E.T. Bastiaans, Silvia
Forcat, Hermione Lyall, Tim R. Cressey, Rawiwan Hansudewechakul, Suparat
Kanjanavanit, Antoni Noguera-Julian, Christoph Königs, Jamie R.J.
Inshaw, Suwalai Chalermpantmetagul, Yacine Saïdi, Alexandra Compagnucci,
Lynda M. Harper, Carlo Giaquinto, Angela P.H. Colbers, and David M.
Burger.Pharmacokinetics of paediatric
lopinavir/ritonavir tablets in children when dosed twice daily according
to FDA weight bands. The Pediatric Infections Disease Journal, March 2014, 33 (3) Lien PubMed
Fontaine H, Kahi S, Chazallon C,
Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saïdi Y, Michel
ML, Scott-Algara D, Aboulker JP, Pol S; for the ANRS HB02 study group. Anti-HBV
DNA vaccination does not prevent relapse after discontinuation of
analogues in the treatment of chronic hepatitis B: a randomised
trial--ANRS HB02 VAC-ADN. Gut. 2014 Feb 20. doi:
10.1136/gutjnl-2013-305707 Lien PubMed
Lutsar I, Chazallon C, Carducci
FI, Trafojer U, Abdelkader B, Meiffrédy V, Esposito S, Giaquinto C,
Heath PT, Ilmoja ML, Katragkou A, Lascoux C, Metsvaht T, Mitsiakos G,
Netzer E, Pugni L, Roilides E, Saidi Y, Sarafidis K, Sharland M, Usonis
V, Aboulker JP; NeoMero Consortium. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr. 2014 Feb 13 Lien PubMed